The in vivo rate of proliferation of Mycobacterium tuberculosis, the causative agent of tuberculosis, has been linked to the rate of progression and severity of disease. Here, we report that deletion of the gene MT2175 (Rv2115c), a putative mycobacterial proteasome-associated AAA-ATPase, leads to a reduction in the growth rate of M. tuberculosis in vitro and in vivo. Despite the reduced growth, the mutant persisted, with slow and gradual clearance in mouse lungs. The mutant elicited reduced levels of interferon-g production in the lungs and, when used as an immunizing agent, provided significan protection against challenge with a virulent strain of M. tuberculosis. Expression of the genes lat and MT3159 were highly up-regulated in the mutant. Thus, loss of MT2175 slows both in vitro and in vivo growth rates and compromises the lethality of M. tuberculosis in mice but has a minimal impact on the organism's ability to persist in host tissues.
from ever contracting TB with effective vaccination against the disease.
Strains of M. tuberculosis that are attenuated for in vivo growth have been shown to provide protection against virulent strains [4] . Virulent strains, such as H37Rv and Erdman, grow more rapidly in mice than do attenuated strains, such as H37Ra and BCG [5] . Therefore, knowledge of genes that regulate the growth rate of M. tuberculosis may further our understanding of the relationship between bacterial expansion and the pathogenesis of TB. In the present study, we describe the role played by the gene MT2175 in growth and virulence in the mouse model of TB.
Some information is available on the biochemical properties of the protein encoded by MT2175. The gene Rv2115c is its homologue in M. tuberculosis H37Rv and shares 100% sequence identity. MT2175 and its homologue in Mycobacterium leprae (ML1316) show 81% sequence similarity to an AAA-ATPase-forming ringshaped complex (ARC) of Rhodococcus erythropolis [6] . In silico domain analysis predicted an N-terminal coiledcoil motif and a C-terminal AAA-ATPase domain. The presence of an N-terminal coiled-coil domain, regarded as a hallmark of proteasomal AAA-ATPases, and the proximity of MT2175 to putative proteasomal genes sug-gest that this gene may be associated with proteasome function. Although the 20S proteasome is ubiquitously present in Eukarya and Archea species, its presence in bacteria is restricted to the phylum Actinobacteria, of which mycobacteria are members [7, 8] . Recent reports have suggested that the protein encoded by the homologue of MT2175 in M. tuberculosis H37Rv is a mycobacterial proteasome-associated ATPase that is involved in responses to nitrosative and oxidative stresses [9] . In addition, Darwin et al. studied the in vivo growth phenotype of this mutant in wild-type (WT) mice and inducible nitric oxide synthase knockout (iNOS Ϫ/Ϫ ) mice and found that iNOS Ϫ/Ϫ mice were more susceptible than the WT mice to the mutant [10] . These observations suggest that the gene is involved in the response to the reactive nitric oxide stress imposed by the host. During a genetic screening of Himar1 transposon mutants of M. tuberculosis, we identifie 3 independent mutants whose colonies were consistently smaller than WT colonies and that had insertions in the gene MT2175. To further assess this observation, and to delineate the role played by this gene in the physiological mechanisms of growth, we created a knockout strain of M. tuberculosis carrying a deletion of MT2175 (hereafter referred to as "DMT2175"). Here, we describe a controlled characterization of the growth rate as well as virulence and transcriptional profile of DMT2175 that demonstrate that it is impaired in in vitro and in vivo growth. In addition, we show that the mutant elicits a muted interferon (IFN)-g response in the lungs of mice and can provide immune protection against virulent WT superinfection when used as a vaccine.
MATERIALS AND METHODS
Bacterial strains, plasmids, and growth conditions. CDC1551, a clinical isolate of M. tuberculosis [11] , was used as the host strain and was grown in either Middlebrook 7H9 plates (supplemented with 0.2% glycerol, 0.05% Tween 80, and 10% [vol/vol] oleic acid-albumin-dextrose-catalase) or Middlebrook 7H10 plates (Becton Dickinson) [12] . The strain DMT2175::res-hygR-res was prepared as described elsewhere [13] , using pYUB854 into which 5 and 3 flank of MT2175 were cloned. This strain was complemented by integrating a single copy of a full-length WT MT2175 carrying its own promoter, using pMH94 [14] . Growth assays were performed in drug-free medium under constant stirring, and colony forming units were counted after 4 weeks of incubation on 7H10 plates at 37ЊC.
Mouse infection. Three groups of 4-5-week-old female BALB/c mice were infected with aerosolized log-phase cultures (OD 600 , 0.77-0.82) of WT M. tuberculosis CDC1551, DMT2175, and the complemented strain (28 mice/group). In vivo growth rates were determined by enumerating bacterial populations in the lungs of mice 1, 21, 49, and 112 days after infection. Twelve mice from each group were retained to assess the time required to reach mortality (time to death). Severe combined immunodeficien Beige mice (Charles River) were used to study the role played by MT2175 in the absence of an adaptive immune response. Three groups of mice (13 mice/group) were infected with aerosolized cultures of WT M. tuberculosis CDC1551, DMT2175, and the complemented strain. Three mice from each group were killed to determine the infecting inoculum. Timeto-death data were collected from the remaining mice. Similarly, for vaccine experiments, 3 groups of BALB/c mice (18 mice/ group) were immunized with a low-dose aerosol of DMT2175, BCG, or control (1ϫPBS) and were aerosol challenged on the 28th day with WT M. tuberculosis CDC1551. Three mice from each group were killed on the days after immunization and challenge to determine the dosages of the immunizing and challenge strains. The remaining mice were used to examine pathological correlates, to determine time to death, and to assess the protective efficac of DMT2175.
IFN-g assay. Homogenates of lungs from the mice infected with WT M. tuberculosis CDC1551, DMT2175, or the complemented strain were serially diluted in 1ϫPBS and filte ed through 0.22-micron sterile syringe filter (Millipore), and 100 mL of each sample filtrat was used to perform ELISAs in 96-well plates, with the antibody AN18 used for coating and the antibody R4-6A2 used for detection (Mabtech). This analysis was repeated 4 times, and purifie mouse IFN-g was included as an internal control.
Microarray and real-time reverse-transcription polymerase chain reaction (RT-PCR). Total bacterial RNAs from WT M. tuberculosis and DMT2175 were extracted from liquid cultures in log phase and were purifie using RNeasy columns (Qiagen). The RNAs were used to prepare amino-allyl-conjugated cDNAs (Atlas Kit; Clontech), which were labeled with Cy3 and Cy5 monofluo escent dyes (Amersham Pharmacia). Equal quantities of Cy3-and Cy5-labeled cDNAs (prepared using RNAs from the WT or DMT2175 strain) were cohybridized (for 16 h at 55ЊC) onto microarray slides representing all open reading frames of M. tuberculosis (Operon Technologies); fluo escence from each probe was recorded using the GenePix 4000B system (Axon Instruments) and was analyzed using Microsoft Excel or the statistical platform R. This analysis was repeated 6 times with independently derived RNA samples. Quantificatio of mRNA transcripts of genes MT3159 and MT3389 was performed by RT followed by quantitative real-time PCR, using SYBR Green Supermix (Bio-Rad Laboratories). mRNA of sigma factor A was used as an internal control for amplificatio and normalization of real-time PCR data.
RESULTS

Reduction of growth rate caused by deletion of MT2175.
We created a collection of 1425 Himar1 transposon insertion mutants of M. tuberculosis CDC1551 and genotyped and screened . Lane 4 shows a marker. Genomic DNA was digested with SmaI and was probed with a labeled fragment of MT2175. The WT DNA shows the 2 expected fragments (1100 and 1240 bp), the DMT2175 DNA shows none, and the DNA from the complemented strain (which had a WT gene integrated at the attB site) shows the 2 predicted bands (1240 and 3048 bp). B, In vitro growth analysis 28 days after plating. Liquid cultures of the WT M. tuberculosis, DMT2175 (knockout [KO]), and the complemented strain were plated on Middlebrook 7H10 medium and photographed on the same day. The average colony size of DMT2175 was much smaller than that of the WT and the complemented strain. Each plate contained similar numbers of colony forming units. C, In vitro growth rates were analyzed by measuring the optical density (at 600 nm ) of cultures of WT M. tuberculosis, DMT2175, and the complemented strain in Middlebrook 7H9 broth at regular time points (right). Aliquots of the culture were plated on Middlebrook 7H10 medium and incubated, and colony forming units were enumerated (left). D, Growth of WT M. tuberculosis, DMT2175, and the complemented strain in mouse lungs. Infected BALB/c mice were killed, and homogenates of lungs were plated on Middlebrook 7H10 medium, to obtain bacillary counts. Each plot represents the number of colony forming units present in the mean ‫ע‬ SD lungs of 4 mice in each group. each mutant for colony size and morphological appearance [15] . A small number of these mutants produced unusually small colonies on enriched medium. Three of these independently created mutants had transposon insertions in the gene MT2175, but they were at 3 different positions (codons 55, 161, and 298). We also created a gene-replacement mutant that lacked 190% of the coding sequence of MT2175, to assess in detail the consequences of the absence of this gene. Additionally, we complemented this deletion knockout with a single copy of the full-length gene expressed from its native promoter (figu e 1A). Although the colonies of DMT2175 were signifi cantly smaller in size compared with those of the WT strain when grown under identical conditions, the full-size colony phenotype was completely restored in the complemented strain (figu e 1B). We then determined the in vitro growth rates of the mutant strain, parental strain, and complemented strain by enumerating the colony forming units and monitoring changes in the optical density of the liquid cultures of the strains (figu e 1C). The average in vitro doubling times, calculated from 3 independent growth measurements in which the colony forming units were enumerated at regular time intervals, were 22 h for DMT2175 and 18 h for the WT strain. At 28 days after plating, the 18-h doubling time for the WT strain would be expected to produce colonies with an average volume of 49 mm 3 , whereas that for mutants would be 0.9 mm 3 (colony volume p cell volume ϫ cell population p [p ϫ cell radius 2 ϫ cell length] ϫ 2 division cycles ). Assuming that colonies are semihemispherical, this model predicts our mutant to give colonies ∼4-fold smaller in diameter than those of the WT strain. As can be seen in figu e 1B, our data correlate well with this prediction. We considered the possibility that the gene MT2175 may be involved in controlling cell size, and its deletion could result in smaller cells, leading to a smaller colony. We tested this hypothesis by scanning electron microscopy and found no difference in cell sizes; both strains measured ∼3.0 mm by 0.4 mm (data not shown).
Next, we assessed the in vivo growth rates of the 3 strains after aerosol infection in immunocompetent BALB/c mice. Day 1 colony forming unit counts confi med the implantation of ∼3.6 log cfu of bacilli in the lungs of mice. Although DMT2175 was able to proliferate during the initial phase of pathogenesis, it increased by only ∼1.5 log cfu, in contrast to the 3.5-4.0 log cfu expansion observed in mice infected with the WT or the complemented strain (figu e 1D). During the chronic phase of infection, from 21 to 112 days, DMT2175 demonstrated persistence with very gradually decreasing abundance, similar to other so-called persistence mutants [16] . These observations show that, in mice, the absence of the gene MT2175 leads to a growth-rate reduction and that there is an overall proliferation of DMT2175 during the initial phase, followed by slow clearance during the chronic phase of infection.
DMT2175 attenuated for lethality in immunocompetent mice. We then investigated the virulence of DMT2175 by assessing time to death and lung disease in BALB/c mice. Similar numbers of WT, DMT2175, and complemented strains were implanted at the time of infection, with a of ∼3.6 mean ‫ע‬ SD ‫ע‬ 0.1 log cfu being recovered from the lungs 24 h after infection. As shown in figu e 2A, the median time to death for the mice infected with either the WT or the complemented strain was 25 days, whereas the mice infected with DMT2175 survived without any signs of disease until 180 days, when the experiment was terminated. With respect to disease, the lungs of mice infected with the WT or the complemented strain showed intense inflammation with many foci of granulomalike cellular infiltrate replacing alveolar air spaces 21 days after infection (figu e 2B). On the other hand, the lung parenchyma of mice infected with DMT2175 had reduced levels of immune infiltrate and ample alveolar air spaces. We also assessed the body weights of mice as a measure of the intensity of disease, as loss of body weight is a hallmark of disease progression. The mice infected with the WT or the complemented strain failed to gain body weight, although their lungs and spleens became progressively inflame and gained mass (figu e 2C). On the other hand, the mice infected with DMT2175 gained weight without any inflammato y gain in mass of their lungs and spleens. These observations led us to conclude that, although the loss of MT2175 produces a M. tuberculosis strain that is able to proliferate in immunocompetent mice, the mutant is severely compromised in its ability to produce lethality and the hallmark tissue damage associated with the murine model of TB. Thus, the DMT2175 mutant produces reduced immunopathological manifestations in mice, as has been described previously for such mutants as M. tuberculosis DsigH, DsigC, and Rel Mtb [17] [18] [19] .
Next, we studied the phenotype of DMT2175 in the absence of a host immune system. The median time to death for severe combined immune deficien (SCID) mice infected with either the WT or the complemented strain was 25 days, and that for the DMT2175-infected group was 27 days (figu e 2D). Because similar numbers of colony forming units of the 3 strains were recovered 1 day after infection ( , ∼2.5 ‫ע‬ 0.2 log mean ‫ע‬ SD cfu), the 2-day time-to-death difference was not statistically significantl different. This pattern of full lethality in SCID mice has been observed for other immunopathological mutants and is consistent with the contention that mutants of this class fail to elicit the same degree of immune-mediated tissue damage [17] .
Lower levels of IFN-g in mice infected with DMT2175. Because DMT2175 caused significantl reduced disease in the lungs, we investigated whether different host inflammato y responses were elicited after infection with the mutant versus the WT strain. BALB/c mice showed no differential response in IFN-g production in the absence of MT2175 1 day after infection. The IFN-g levels remained unchanged even at 21 days after infection in the mice infected with DMT2175, whereas the mice infected with the WT or the complemented strain had 14-fold higher levels of IFN-g (figu e 3). These data correlated well with the observed histopathological manifestations: the lungs of the mice infected with the WT or the complemented strain were fille with large numbers of macrophages and lymphocytes, whereas the lungs of the mice infected with DMT2175 contained fewer infiltrate and a greater abundance of patent alveolar spaces (figu e 2B). The levels of IFN-g in the mice infected with the mutant strain were slightly higher at 49 and 112 days after infection but failed to reach the levels observed in the mice infected with the WT or the complemented strain. Thus, we conclude that the loss of the gene MT2175 leads to a reduced level of IFN-g production and, hence, a milder Th1 immune response in mice.
Protection against virulent M. tuberculosis provided by immunization of mice with DMT2175. The decreased virulence of DMT2175, as evidenced by the diminished level of in vivo growth, reduced lung disease, and prolonged time to death, led us to assess its ability to provide immunological protection against WT M. tuberculosis infection. Three groups of mice were immunized with either BCG, DMT2175, or PBS (control), and the colony forming unit counts in the lungs were mean ‫ע‬ SD , , and 0, respectively, 24 h after immu-1660 ‫ע‬ 85 1460 ‫ע‬ 86 nization. After 28 days, the mice were aerosol challenged with Mycobacterium bovis bacille Calmette-Guérin (BCG), or 1ϫPBS (CONTROL). The mice were then infected with wild-type Mycobacterium tuberculosis after 28 days, and times to death were recorded. The median time to death in the control group was 40 days, whereas the mice immunized with either BCG or DMT2175 showed no signs of morbidity until ∼170 days (the experiment was terminated at 300 days after challenge).
WT M. tuberculosis, with a of ∼ cfu mean ‫ע‬ SD 4383 ‫ע‬ 333 being recovered per mouse lung the following day. The median time to death for the control group was 40 days, whereas the groups immunized with either BCG or DMT2175 showed no signs of severe disease or fatality until 170 days after the challenge (figu e 4); this difference was statistically significan ( , Kaplan-Meier test). It is notable that this strain, which P ! .01 is derived from the virulent M. tuberculosis clinical isolate CDC1551, was able to protect against mortality due to TB and to extend the life of mice by ∼120 days.
Differential up-regulation of genes lat (MT3389) and MT3159 in DMT2175. We studied changes in the transcriptome by comparing the levels of individual transcripts in WT and DMT2175 by use of whole genome microarrays. This experiment revealed 5 genes to be differentially up-regulated in DMT2175. Further analysis using quantitative real-time RT-PCR with gene-specifi primers showed only 2 of the 5 genes to be consistently overexpressed in DMT2175. The mRNA levels of these genes-MT3159 (Rv3074) and lat (L-lysine epsilon aminotransferase; MT3389 [Rv3290c])-were higher by a factor of and , compared with mean ‫ע‬ SD 14.5 ‫ע‬ 8.1 12.9 ‫ע‬ 3.1 that in the WT strain. MT3159 (Rv3074) is annotated as a gene of unknown function. Its genomic locus shows that it is not a part of an operon, because the flankin genes are transcribed in opposite directions (http://www.tigr.org). A recent report suggests that this gene may be regulated by LexA, a protein involved in DNA excision and repair during SOS response [20] . A homologue of the gene lat is present in both M. bovis (Mb3318c) and M. leprae (ML0721) but is nonessential for the in vitro survival of M. tuberculosis [15, 21] . This gene has been implicated in metabolism, and a 42-fold increase in its expression under nutrient-starvation conditions has been reported [22] . The relation between these genes and MT2175 is not obvious from what is known and warrants further investigation.
DISCUSSION
Genes encoding putative 20S proteasome are present in species belonging to the phylum Actinobacteria, of which mycobacteria are members. Its function, however, is not essential for axenic growth of Mycobacterium smegmatis [23] . Recently, MT2175 (Rv2115c) was proposed to be one of the subunits of mycobacterial proteasome, on the basis of it sequence homology with ARC of R. erythropolis, close proximity to the gene prcAB, and the effect of proteasome inhibitors on the proteolytic activity of M. tuberculosis lysate on peptide substrates [9, 10] . Here, we report that the gene MT2175 is required for normal in vitro and in vivo growth and virulency of M. tuberculosis.
The pathogenesis of TB has been widely recognized as an interplay between the infecting bacterial mass and the host immune response. The recruitment of a robust supply of activated macrophages and lymphocytes in the lungs is believed to suppress bacterial multiplication and growth [24] . It is therefore reasonable to conjecture that reduced growth rate of the bacteria may permit the host enough time to generate an effective immune response and limit pathogenesis of the disease. We tested this hypothesis by infecting mice with WT M. tuberculosis, DMT2175, and a complemented strain. The reduced inflammatio and disease in the lungs and spleens was exclusively observed in mice infected with DMT2175, which is characteristic of a class known as the "immunopathology mutants," because they persist in the lungs and/or spleen but do not cause significan immune-induced disease. Deletion of genes such as sigH, sigC, and Rel Mtb result in mutants that are capable of persisting without causing extensive disease and morbidity [17] [18] [19] .
IFN-g is an important immune effector molecule that is secreted primarily by T cells in response to M. tuberculosis infection, and it activates macrophages for intracellular killing. Reduced levels of IFN-g have been reported in patients with active TB [25] , and those with a defective IFN-g receptor are susceptible to infection with otherwise nonpathogenic mycobacteria [26] . Treatment with aerosolized IFN-g has shown therapeutic value in patients infected with multidrug-resistant TB [27] . Mice lacking the gene for IFN-g are susceptible to mycobacterial infection, because they develop granulomas and undergo extensive destruction of lung parenchyma, leading to premature death [28] [29] [30] . In addition, IFN-g-deficien mice are unable to control bacterial growth and tissue necrosis but show delayed development of disease when being treated with exogenous IFN-g [31] . In the present study, we observed that immunocompetent mice displayed a muted IFN-g response when infected with DMT2175 and lived much longer than those infected with WT M. tuberculosis. Similar levels of IFN-g were observed at the onset of infection in the lungs of mice infected with similar doses of the WT, DMT2175, or complemented strains. Yet, IFN-g levels failed to increase only in the mice infected with DMT2175 during the acute phase of infection, despite an increase in colony forming unit counts (figu es 1D and 3). It may be argued that rapid proliferation of either colony forming units, as exhibited by the WT or the complemented strain, or effector molecules that are not related to growth but that are affected by the loss of MT2175 is required to elicit higher levels of IFN-g. Whether this effect is mediated directly by the loss of MT2175 or indirectly through other genes differentially affected by it, such as MT3159 and lat, remains to be elucidated.
The inability of DMT2175 to cause effective disease, morbidity, and mortality prompted us to examine whether it could provide immunity against the pathogenesis of TB caused by WT M. tuberculosis. In addition, the observation that DMT2175 can persist chronically would make it ideal for presenting antigens for a protracted period of time. Although the mouse model is believed to be inadequate to fully assess the immune properties of a prospective vaccine, DMT2175 and BCG did confer similar levels of protection against the pathogenesis of TB. The ability of DMT2175 to extend the life of mice by 120 days is noteworthy and, therefore, warrants further study in animals that form tuberculous granulomas and caseating cavities, to assess the relevance of protective efficac of this strain in humans. Thus, DMT2175 shows interesting properties as a live attenuated vaccine for TB and could play a role in generating a safe and effective M. tuberculosis-derived vaccine [32] .
We investigated the molecular mechanisms that may explain the growth attenuation and associated phenotypes of the mutant by examining its transcription profil and found 2 genes whose expression was highly induced in the mutant only. These genes, lat and MT3159, have not been associated with cell cycle regulation or growth. Although lat has been implicated in metabolism, it has been shown that this gene is not required for in vitro survival [15, 21] . The gene MT3159 encodes a protein of unknown function. In silico genomic and proteomic analysis do not reveal any obvious association of these proteins with MT2175, thus warranting further study of this finding
Here, we have presented data indicating the that loss of the gene MT2175 leads to a reduced in vitro and in vivo growth rate of M. tuberculosis and severely compromises its lethality in mice. The mutant lacking the gene failed to induce robust levels of IFN-g and produced limited tissue damage in mice. The mutant persisted for an extended period of time in diminished numbers and, when used as a vaccine, provided immune protection against the pathogenesis of disease by virulent WT M. tuberculosis.
